Telehealth Anxiety Prescribing: What PMHNPs Can Do in California

If you’re a psychiatric provider considering telehealth work or just trying to understand your prescribing authority for anxiety medications, you’ve probably noticed the rules aren’t simple. The short answer: yes, nurse practitioners can prescribe anxiety meds — including controlled substances like benzodiazepines — but the conditions under which they can do so vary wildly by state. Psychiatrists, on the other hand, can prescribe any anxiety medication independently in all 50 states.

This matters because anxiety disorders are among the most common mental health conditions in America, and demand for medication management is surging. Understanding your scope of practice — and how it differs from a colleague’s in another state or provider type — directly affects your ability to build a thriving practice, especially via telehealth.

Let’s break down what psychiatrists and PMHNPs can actually do when it comes to prescribing anxiety medications, how federal and state rules shape your practice, and what it means for your career on a platform like Klarity.

The Federal Picture: Telehealth Prescribing Is Still Wide Open (For Now)

Here’s the good news: as of February 2026, federal rules still allow you to prescribe controlled substances for anxiety via telehealth without an initial in-person visit. This is thanks to COVID-era flexibilities that the DEA and HHS have extended through December 2026.

What does this mean practically? A psychiatrist or PMHNP (in states where they have authority) can:

• Conduct an initial evaluation via video
• Prescribe SSRIs, SNRIs, buspirone, beta-blockers
• Prescribe benzodiazepines (alprazolam, clonazepam, lorazepam — all Schedule IV controlled substances)
• Even prescribe Schedule II medications like stimulants for comorbid ADHD, all without ever seeing the patient face-to-face

In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine. The extension through 2026 prevents what regulators call a ‘telemedicine cliff’ — where millions of patients would suddenly lose access if providers had to revert to pre-pandemic rules requiring in-person visits.

The catch: permanent rules are coming. The DEA is expected to finalize regulations in late 2026 that may introduce new requirements — possibly a special telemedicine registration or some exam protocols. For now, though, the path is clear for remote anxiety treatment.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State Rules: Where It Gets Complicated

Federal law sets the baseline, but state practice acts determine who can prescribe what. This is where the psychiatrist vs. PMHNP distinction becomes critical.

Psychiatrists: Full Authority, Everywhere

If you’re a psychiatrist (MD/DO), your prescribing authority for anxiety is straightforward:

• You can prescribe any anxiety medication in all 50 states
• No supervision required
• No collaborative agreements
• No quantity limits (beyond standard medical practice)

The only compliance requirements: check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances, follow DEA registration rules, and meet standard of care documentation.

PMHNPs: It Depends Where You Practice

Psychiatric Mental Health Nurse Practitioners have deep training in psychiatric medication management — but their legal authority to prescribe anxiety meds varies dramatically by state. States fall into three categories:

Full Practice Authority (FPA) States: About half of U.S. states grant PMHNPs the right to evaluate, diagnose, and prescribe medications (including controlled substances) independently. In these states, a PMHNP’s authority is functionally equivalent to a psychiatrist’s for anxiety treatment.

Examples:

• New York (FPA since 2022) — no physician oversight required
• Oregon, Washington, Arizona — long-standing FPA states
• California (transitioning) — experienced NPs can now practice independently via the new 103/104 NP categories (full independence available starting 2026 for qualified NPs)

Reduced Practice States: PMHNPs can prescribe but must maintain a collaborative agreement with a physician. The physician doesn’t co-sign every prescription, but there’s periodic chart review and availability for consultation.

Examples:

• Illinois — requires collaboration initially, but PMHNPs with 4,000 clinical hours + 250 CE hours can obtain full practice authority (with one caveat: a physician must sign off on controlled substance authority initially)
• Florida — requires written protocols with a supervising physician; psychiatric NPs can prescribe more than 7 days of controlled substances for mental health treatment (unlike other NPs)

Restricted Practice States: PMHNPs need direct physician supervision for prescribing, often with significant limitations on controlled substances.

Examples:

• Texas — requires physician delegation agreement; NPs cannot prescribe Schedule II drugs (like stimulants) outside hospital settings; benzodiazepines allowed if physician authorizes
• Pennsylvania — requires collaborative agreement for entire career; physician must review 100% of Schedule II prescriptions within 24 hours

Real-World Impact: What This Means for Anxiety Treatment

Let’s say you’re a PMHNP treating a patient with generalized anxiety disorder who’s been on an SSRI but needs a short-term benzodiazepine for breakthrough symptoms:

• In New York: You evaluate the patient via telehealth, review the state PDMP, and prescribe a 30-day supply of clonazepam independently. Done.

• In Texas: You must have a prescriptive authority agreement with a physician. You can prescribe the clonazepam (Schedule IV), but only if your delegating physician has explicitly authorized it in your agreement. If the patient also has ADHD and needs a stimulant (Schedule II), you likely cannot prescribe it at all in an outpatient setting.

• In Pennsylvania: You evaluate the patient and determine a benzodiazepine is appropriate, but your collaborative agreement with a psychiatrist must explicitly include benzodiazepines in your formulary. You write the prescription, and your supervising psychiatrist reviews the chart within the required timeframe.

This isn’t just administrative hassle — it affects patient access. In states with restrictive rules, if a PMHNP can’t find a physician willing to collaborate (common in rural areas), they effectively cannot practice psychiatric care at all, despite being fully trained to do so.

State-by-State Breakdown: Where You Can Do What

California: In Transition

California is mid-shift from one of the most restrictive states to allowing NP independence. Until recently, PMHNPs needed physician-approved standardized procedures for every medication.

What changed: AB 890 (2020) created a pathway where experienced NPs can practice without standardized procedures. As of January 2023, qualified NPs can become ‘103 NPs’ and work in group settings with at least one physician in the organization. Starting January 2026, those with three years of 103 NP experience can become ‘104 NPs’ and practice fully independently.

For anxiety prescribing: If you’re an experienced PMHNP in California reaching 104 status in 2026, you can now open your own telehealth practice managing anxiety medications (including controlled substances) without physician oversight — a massive change from the prior requirement.

Psychiatrists: Full independence always. No telehealth restrictions on prescribing controlled substances.

Texas: Tight Restrictions

Texas remains one of the hardest states for NP practice. All PMHNPs must have a prescriptive authority agreement with a Texas physician.

The Schedule II problem: Texas law prohibits NPs from prescribing Schedule II controlled substances in outpatient settings (exceptions: hospital-based care for admitted patients, hospice, or terminally ill). This means if you’re treating anxiety with comorbid ADHD and want to prescribe Adderall, an NP cannot do it outside a hospital — the psychiatrist must.

For benzodiazepines: PMHNPs can prescribe them (Schedule IV) if the delegating physician authorizes it in the agreement and the NP has a DEA registration.

Telehealth note: Texas allows telemedicine prescribing but prohibits treating ‘chronic pain’ with controlled substances via telehealth. Anxiety treatment doesn’t fall under this — so remote prescribing of anxiolytics is permitted.

Psychiatrists: Can prescribe anything, anywhere in Texas, including via telehealth.

Florida: Psychiatric Carve-Out

Florida requires PMHNPs to practice under written protocols with a physician. However, there’s an important exception for psychiatric NPs:

Controlled substance limits: Florida generally restricts NPs to a 7-day supply of controlled substances. BUT — if you’re a psychiatric nurse practitioner treating a mental health disorder, you’re exempt from this 7-day rule. You can prescribe a month of Xanax for generalized anxiety disorder, for instance.

Telehealth prescribing: Florida prohibits teleprescribing of Schedule II controlled substances except for psychiatric disorders. So a Florida-licensed psychiatrist or PMHNP treating anxiety can prescribe stimulants for comorbid ADHD via telehealth legally.

Out-of-state providers: Florida allows out-of-state providers to register for telehealth-only practice, but they cannot prescribe controlled substances remotely unless they have a full Florida license.

Psychiatrists: Full authority, including teleprescribing of controlled meds for psychiatric treatment.

New York: Full Parity for NPs

New York is now one of the most NP-friendly states. As of 2022, PMHNPs no longer need collaborative agreements or written protocols.

What you can do: A PMHNP in New York can open their own practice, evaluate patients for anxiety, prescribe any medication (SSRIs, benzodiazepines, even stimulants if clinically appropriate), all independently.

The only difference from a psychiatrist: NPs are licensed through the Board of Nursing rather than the Board of Medicine, and Medicare reimburses NPs at 85% of physician rates.

Telehealth: No state restrictions. Must check the state PDMP (iSTOP) before prescribing any controlled substance — this is one of the strictest PDMP mandates in the country.

Pennsylvania: Collaboration Required for Life

Pennsylvania requires all NPs to maintain a collaborative agreement with a physician for their entire career (unless laws change). For psychiatric NPs, this typically means partnering with a psychiatrist.

Prescribing rules: The agreement must specify which drug categories the NP can prescribe. For Schedule II medications, the physician must review and countersign the chart within 24 hours. For benzodiazepines (Schedule IV), physician review is required but the timeline is less strict (usually within 10 days).

Practically: Many collaborative agreements in psychiatric settings do allow PMHNPs to prescribe benzodiazepines for anxiety — but if your collaborating psychiatrist is uncomfortable with it, you may be blocked.

Psychiatrists: Independent practice, no oversight required.

Illinois: Path to Independence

Illinois starts NPs with required collaboration but offers a path to full practice authority.

The pathway: Complete 4,000 hours of clinical practice + 250 hours of additional CE, then apply for Full Practice Authority. Once granted, you can practice independently — with one twist: you need a physician to sign off that you’ll be prescribing controlled substances (a one-time attestation, not ongoing supervision).

For anxiety prescribing: An Illinois PMHNP with FPA can prescribe benzodiazepines after that initial physician sign-off. New grads must work under a collaborative agreement where the physician explicitly delegates controlled substance prescribing.

Psychiatrists: Independent from day one.

Reimbursement: What You’ll Actually Get Paid

Understanding prescribing authority is only half the picture — you need to know what you’ll earn for medication management visits.

Medicare Rates (2026)

Medicare is the benchmark most insurers follow:

• Initial psychiatric evaluation (90792): ~$202
• 15-minute medication check (99213): ~$95
• 25-minute follow-up (99214): ~$136
• Therapy add-on for 30 minutes (90833): ~$81

NP reimbursement: Medicare pays NPs at 85% of physician rates when they bill under their own NPI. So a PMHNP doing a 15-minute med check would get ~$81 instead of $95.

Medicaid Rates

Medicaid varies by state but typically pays 50-60% of Medicare rates:

• Initial eval: ~$85 (vs $202 Medicare)
• 15-min follow-up: ~$40-50 (vs $95 Medicare)

The volume can offset lower rates, and many states have improved Medicaid reimbursement for mental health recognizing shortages.

Private Insurance

Commercial plans typically pay 100-150% of Medicare rates. A med check might reimburse $100-$130 depending on the contract.

Telehealth Parity

Thanks to state parity laws and temporary federal extensions, telehealth visits are paid at the same rate as in-person in most cases through at least 2026. States like California, Illinois, and New York have permanent telehealth parity laws for mental health services.

Important note for Medicare: There was a proposed rule requiring an in-person visit within 6 months to continue tele-mental health services, but enforcement has been delayed through 2025 and likely into 2026. Watch for updates.

How Klarity Solves the Economics Problem

Here’s the reality most providers face when building a practice: patient acquisition is expensive and unpredictable.

If you’re trying to market your anxiety treatment services yourself:

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow (and most solo providers don’t have that expertise or patience)
• Google Ads for mental health keywords cost $15-40+ per click, and most clicks don’t convert — realistic cost per booked patient is $200-400+
• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers on the same page
• When you factor in agency fees, ad spend testing, staff time to handle leads, no-show rates from cold leads, and failed campaigns, acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+

Klarity uses a different model: pay per qualified appointment. Instead of gambling $3,000-5,000/month on marketing with uncertain results, you pay a standard listing fee only when a pre-qualified patient books with you.

The value props:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

This is the smart economic choice: instead of risking thousands on marketing channels you don’t control, you get guaranteed ROI. You only pay when a patient shows up.

FAQ: Anxiety Medication Prescribing Authority

Can a nurse practitioner prescribe Xanax or other benzodiazepines?

Yes, but it depends on the state. In Full Practice Authority states (like New York, Oregon, Washington), PMHNPs can prescribe benzodiazepines independently. In states requiring collaboration (like Texas, Pennsylvania, Florida), they need physician authorization in their collaborative agreement. All NPs must have a DEA registration to prescribe controlled substances.

Can psychiatrists prescribe anxiety medication via telehealth in 2026?

Yes. Federal rules currently allow psychiatrists to prescribe controlled substances (including benzodiazepines) via telehealth without an initial in-person visit, through December 2026. State rules vary slightly — some states like Florida have carve-outs allowing controlled substance prescribing for psychiatric treatment specifically.

What’s the difference between a psychiatrist and a PMHNP for anxiety treatment?

Both can provide excellent anxiety medication management, but legal authority differs. Psychiatrists (MD/DO) can prescribe independently in all states with no supervision. PMHNPs have prescribing authority that ranges from fully independent (in FPA states) to requiring physician oversight (in restricted states). Training also differs: psychiatrists complete 4 years of medical school + 4 years of residency; PMHNPs typically have 2-3 years of graduate training focused on psychiatric care.

Do I need a physician to supervise my anxiety prescribing as an NP?

It depends where you’re licensed. In about half of U.S. states (FPA states), no supervision is required. In the rest, you need some form of collaborative agreement or supervision. Check your state’s Board of Nursing regulations for specifics.

Can PMHNPs prescribe Schedule II medications like Adderall for anxiety patients with ADHD?

In Full Practice Authority states, yes. In restricted states, often no — Texas specifically prohibits NPs from prescribing Schedule II outside hospital settings; Florida limits Schedule II prescriptions to 7 days unless you’re a psychiatric NP treating mental illness; Pennsylvania requires immediate physician review of all Schedule II prescriptions.

What states allow nurse practitioners to prescribe independently?

As of 2026, roughly 25-28 states plus D.C. grant Full Practice Authority to NPs. For psychiatric practice specifically, key FPA states include: New York, Oregon, Washington, Arizona, Alaska, Montana, Idaho, Wyoming, North Dakota, South Dakota, Nebraska, Iowa, Wisconsin, Minnesota, Maryland, Maine, Vermont, New Hampshire, Rhode Island, Connecticut, New Mexico, Hawaii, Nevada. California is transitioning (104 NPs will have full independence in 2026). Illinois offers FPA after meeting experience requirements.

How much can I make doing medication management for anxiety on a telehealth platform?

It depends on the payment model. Medicare reimburses ~$95 for a 15-minute med check, ~$136 for 25 minutes. Medicaid pays less (~$40-85). Private insurance typically pays $100-130. If the platform pays per visit (after taking a service fee), you might earn $70-100 per appointment. With efficient scheduling (4-6 patients per hour for brief med checks), telehealth psychiatry can be quite lucrative — experienced providers often earn $200-300+ per hour.

Do I need to check the prescription monitoring database before prescribing anxiety medications?

Yes, for controlled substances. Every state has a Prescription Drug Monitoring Program (PDMP) and most require you to check it before prescribing any controlled substance (including benzodiazepines for anxiety). Some states mandate checks every time; others require it at initiation and periodically thereafter (e.g., every 90 days). This applies to both psychiatrists and NPs.

Join Klarity’s Provider Network

If you’re a psychiatrist or PMHNP looking to treat anxiety patients via telehealth without the headache of marketing, credentialing, and platform management, Klarity handles all of that.

Why providers choose Klarity:

• Get matched with pre-qualified anxiety patients actively seeking treatment
• No upfront costs — pay only when patients book
• Work across state lines (where you’re licensed)
• Keep your schedule flexible
• Focus on clinical care, not patient acquisition

Whether you’re in a Full Practice Authority state and want to leverage your independence, or you’re in a restricted state and need physician collaboration support, Klarity’s platform is built to accommodate your licensing reality.

Ready to grow your anxiety treatment practice? Join Klarity’s provider network and start seeing patients this month.

Sources and References

1. U.S. Department of Health and Human Services. (2026, January 2). ‘HHS & DEA Extend Telemedicine Flexibilities Through 2026.’ www.hhs.gov

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth Prescribing Rules. Florida Senate. (2024). www.flsenate.gov

3. California Board of Registered Nursing. (2024). ‘AB 890 Implementation: Advanced Practice Registered Nurse Certification.’ rn.ca.gov

4. Nurse Practitioner Association of New York. (2022, April 9). ‘Breaking News: NP Modernization Act Passes – Full Practice Authority for NYS NPs.’ npny.enpnetwork.com

5. TheraThink. (2025). ‘Insurance Reimbursement Rates for Psychiatrists in 2026: Complete Guide.’ therathink.com

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs